Lucentis for Myopic Choroidal Neovascularization User Reviews
Lucentis has no reviews submitted for this condition. Be the first to review this drug.
More about Lucentis (ranibizumab ophthalmic)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (15)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
